EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer therapy–related salivary dysfunction

Cristina Paz, Annemarie Glassey, Abigail Frick, Sarah Sattar, Nicholas G Zaorsky, Grace C Blitzer, Randall J Kimple

Journal of Clinical Investigation · 03.09.2024 · 134 (17)

DOI: 10.1172/jci182661 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.09.2024. Verfasst von Cristina Paz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Salivary Glands, Neoplasms, Xerostomia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salivary gland dysfunction is a common side effect of cancer treatments. Salivary function plays key roles in critical daily activities. Consequently, changes in salivary function can profoundly impair quality of life for cancer patients. We discuss salivary gland anatomy and physiology to understand how anticancer therapies such as chemotherapy, bone marrow transplantation, immunotherapy, and radiation therapy impair salivary function. We discuss approaches to quantify xerostomia in the clinic, including the advantages and limitations of validated quality-of-life instruments and approaches to directly measuring salivary function. Current and emerging approaches to treat cancer therapy–induced dry mouth are presented using radiation-induced salivary dysfunction as a model. Limitations of current sialagogues and salivary analogues are presented. Emerging approaches, including cellular and gene therapy and novel pharmacologic approaches, are described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary GlandsNeoplasmsXerostomiaHumansRadiotherapyQuality of LifeAnimalsImmunotherapyAntineoplastic Agents

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA.
  • Case Western Reserve University, Cleveland, Ohio, USA.
  • University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Förderung

  • NIDCR NIH HHS
  • NCI NIH HHS

Zitieren

APA

Paz, C., Glassey, A., Frick, A., Sattar, S., Zaorsky, N. G., Blitzer, G. C., & Kimple, R. J. (2024). Cancer therapy–related salivary dysfunction. Journal of Clinical Investigation, 134(17). https://doi.org/10.1172/jci182661

Vancouver

Paz C, Glassey A, Frick A, Sattar S, Zaorsky NG, Blitzer GC, et al. Cancer therapy–related salivary dysfunction. Journal of Clinical Investigation. 2024;134(17). doi:10.1172/jci182661

BibTeX
@article{Paz2024,
  author = {Paz, Cristina and Glassey, Annemarie and Frick, Abigail and Sattar, Sarah and Zaorsky, Nicholas G and Blitzer, Grace C and Kimple, Randall J},
  title = {Cancer therapy–related salivary dysfunction},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {17},
  doi = {10.1172/jci182661}
}
Kostenlos starten →